Bangkok--Sep 25--Curtin University of Technology
Hospitals around the world will soon be using special test kits - developed by biomedical scientists at Curtin University of Technology - to better detect infections that are one of the major causes of death in cancer patients.
The new test kits, expected to be on the market before the end of the year, will test for Candida infection - also a major cause of mortality in bone marrow and liver transplant patients.
Most people know that Candida is the causative agent of thrush, but it is also the fourth most common pathogen isolated from the blood of patients in hospital intensive care units.
There has also been a large increase in oral thrush in association with the AIDS epidemic. The appearance of oral thrush in HIV positive patients is one of the first indications they are about to develop full-blown AIDS.
Associate Professor John Warmington, the head of Curtin's Candida Research Unit, said the Candida test kits will be used by hospital pathology departments and private pathology labs to more quickly and efficiently check patient blood samples.
The Unit is in the School of Biomedical Science - part of Curtin's Division of Health Sciences - the biggest of its kind in Australia
The development of the kits, being marketed by PanBio Pty Ltd, comes on top of the Unit's world breakthrough in identifying one of the immunodominant antigens of Candida.
"This Candida test kit is one of only a few of its kind and will enable pathologists to carry out accurate and efficient tests in about an hour and a half," Associate Professor Warmington said.
"We expect the kits to become widely used to improve Candida testing and to benefit doctors and patients through quicker diagnosis. Ultimately, early diagnosis of Candida infections will result in earlier, more effective treatment, fewer people dying from the infection, and shorter hospital stays. "
The Candida Research Unit is using a combined molecular biological and immunological approach to identify components of Candida which cause adaptive immune responses in humans and mouse models of the infection.
Curtin, one of Australia's most dynamic and innovative higher education institutions, has been ranked by the Australian Government's Quality Assurance Committee, as being among Australia's top universities in research management process, research improvement and community service.
A recent Asiaweek survey identified Curtin as the best science and technology university in Australia, and third in the Asian region for academic reputation.
Curtin was the first of the 'new' universities to be awarded a number one ranking in the concluding round of the Federal Government's national quality reviews of Australian universities (1995).
The University has a strong research profile in a wide range of disciplines and is a principal member in six Commonwealth Cooperative Research Centres (CRCs).
This is the strongest involvement of any university within the Australian Technology Network universities (ATN).
Curtin has established formal agreements in 30 countries and has offshore programs in Singapore, Hong Kong, Malaysia, Indonesia and Taiwan. Curtin staff have informal academic and research collaborative links in 37 countries.
For more information please contact Sally Rowe Media Coordinator Curtin University of Technology Perth, Western Australia Tel: (+ 61 8) 9266 2793 Mobile: 0417 945 889 E-mail: [email protected] End.